XML 38 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2025
Stock-Based Compensation [Line Items]  
Schedule of Share Option Plan

The following is a summary of the status of the Company’s share option plan as of March 31, 2025:

 

   Three months ended 
   March 31, 2025 
   Number of Options   Weighted-
Average
Exercise
price		 
Options outstanding as of December 31, 2024   10,569,170   $1.07 
Granted during the period   511,925   $2.41 
Exercised during the period   (246,513)  $0.76 
Forfeited during the period   (16,563)  $2.10 
Options outstanding as of March 31, 2025   10,818,019   $1.14 
Options exercisable as of March 31, 2025   10,028,826   $1.02 
Schedule of Information about Share Options Outstanding

The following table summarizes information about stock options outstanding as of March 31, 2025:

 

Outstanding as of March 31, 2025   Exercisable as of March 31, 2025 
Range of
exercise
prices		   Number
outstanding		   Weighted
average
remaining
contractual
term		   Weighted
average
exercise
price		   Aggregate
intrinsic
value
(U.S. dollars in
thousands)		   Number
Exercisable		   Weighted
average
remaining
contractual
term		   Weighted
Average
exercise
price		   Aggregate
intrinsic
value
(U.S. dollars
in thousands)		 
$0.15-$0.86    9,396,260    3.70    0.80    11,652    9,348,838    3.69    0.80    11,596 
$1.87    3,313    5.78    1.87    1    3,313    5.78    1.87    1 
$2.10-$2.13    55,710    6.50    2.13    
-
    9,285    6.50    2.13    
-
 
$2.39-$2.41    937,194    6.34    2.40    
-
    341,221    5.79    2.39    
-
 
$4.99    196,625    4.80    4.99    
-
    141,002    4.80    4.99    
-
 
$5.36    140,000    4.25    5.36    
-
    96,250    4.25    5.36    
-
 
$7.58    85,380    3.79    7.58    
-
    85,380    3.79    7.58    
-
 
$9.07    3,537    3.71    9.07    
-
    3,537    3.71    9.07    
-
 
Schedule of Fair Value of Stock-Based Compensation Awards

The calculated fair value of option grants was estimated using the Black-Scholes option-pricing model with the following assumptions:

 

   For the
three months
ended on
March 31,
2025		   For the
three months
ended on
March 31,
2024		 
Expected term   4-5    4-5 
Expected volatility   59.63%-63.35%   58.56%
Expected dividend rate   0%   0%
Risk-free rate   4.34%-4.36%    3.85%-3.92% 
Schedule of Classification of Stock Options Expenses

The following table presents the classification of the stock options expenses for the periods indicated:

 

   Three months Ended
March 31		 
   2025   2024 
   U.S. dollars in thousands 
Cost of revenue   27    44 
Research and development   135    223 
Sales and marketing   58    249 
General and administrative   163    376 
Total stock-based compensation   383    892 
Schedule of Company’s RSU’s

The following is a summary of the status of the Company’s RSU’s as of March 31, 2025, as well as changes during the period of nine months ended March 31, 2025:

 

   Number of
RSUs		   Weighted-
Average
Grant
Date Fair
Value		 
RSUs outstanding at the beginning of the year   8,827,092   $3.13 
Granted during the period   4,518,634   $2.14 
Vested during the period   (1,533,878)  $2.90 
Forfeited during the period   (76,332)  $2.67 
Outstanding at the end of the period   11,735,516   $2.79 
Schedule of Classification of RSU's Expenses

The following table presents the classification of RSU’s expenses for the periods indicated:

 

   Three months ended
March 31		 
   2025   2024 
   U.S. dollars in thousands 
Cost of revenue   223    187 
Research and development   1,736    1,445 
Sales and marketing   1,169    727 
General and administrative   655    513 
Total stock-based compensation-RSUs   3,783    2,872